Improving CD3 bispecific antibody therapy in solid tumors using combination strategies

被引：0
|
作者：
Lloyd, Katy [1 ]
Middelburg, Jim [2 ]
Ovcinnikovs, Vitalijs [1 ]
Pencheva, Nora [1 ]
Kemper, Kristel [1 ]
van Hall, Thorbald [2 ]
机构：
[1] Genmab BV, Utrecht, Netherlands
[2] Leiden Univ, Oncode Inst, Med Ctr, Dept Med Oncol, Leiden, Netherlands
来源：
FRONTIERS IN ONCOLOGY | 2025年 / 15卷
关键词：
antibody; CD3; bispecific Ab; cancer; vaccination; T-CELL ENGAGER; CANCER; EXPANSION; CYTOTOXICITY; BLOCKADE; MYELOMA;
D O I：
10.3389/fonc.2025.1548446
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CD3 bispecific antibodies (bsAbs) are emerging as an important treatment option in the arsenal of oncologists. There are numerous FDA-approved CD3 bsAbs for both hematological and solid tumors. Despite these recent advances, the success of CD3 bsAbs in solid cancer has been hampered by hurdles like limited intratumoral T cell numbers, immunosuppressive tumor microenvironments (TME), and poor memory T-cell induction. Furthermore, tumor surface antigen selection for an optimal therapeutic window and acceptable collateral damage to normal tissues is challenging. In this review, we discuss recent research investigating combination approaches aimed at improving CD3 bsAb efficacy in solid cancer.
引用
收藏
页数：8
相关论文
共 50 条
  • [31] T Cells from CLL Patients on Venetoclax Mount Potent Cytotoxic Responses in Combination with Epcoritamab, a CD20/CD3 Bispecific Antibody
    Saleh, Layla M.
    Mhibik, Maissa
    Playa-Albinyana, Heribert
    Sun, Clare
    Pleyer, Christopher
    Wiestner, Adrian
    BLOOD, 2024, 144 : 3231 - 3232
  • [32] Construction, expression and identification of bispecific antibody for targeting CD3 and B7-H3.
    Zhang, K.
    Gui, F.
    Wang, J.
    Pan, Y.
    Yang, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1743 - 1743
  • [33] A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era
    Robinson, Hannah R.
    Qi, Junpeng
    Cook, Erika M.
    Nichols, Cydney
    Dadashian, Eman L.
    Underbayev, Chingiz
    Herman, Sarah E. M.
    Saba, Nakhle S.
    Keyvanfar, Keyvan
    Sun, Clare
    Ahn, Inhye E.
    Baskar, Sivasubramanian
    Rader, Christoph
    Wiestner, Adrian
    BLOOD, 2018, 132 (05) : 521 - 532
  • [34] Preclinical Characterization of an ANTI-CD38/CD3 T CELL-Redirecting Bispecific Antibody
    He, Xiao
    Zhang, Yanliang
    Lai, Yun Wei
    Baguley, Stephanie
    Li, Yan
    Cao, Xia
    Yan, Ying
    Takeshita, Ken
    Zeldis, Jerome B.
    Ji, Henry
    Kaufmann, Gunnar F.
    BLOOD, 2019, 134
  • [35] Safety, Pharmacodynamic, and Antitumor Activity of Tidutamab, an SSTR2 x CD3 Bispecific Antibody, in Subjects With Advanced Neuroendocrine Tumors
    El-Rayes, Bassel F.
    Hendifar, Andrew E.
    Pant, Shubham
    Wilky, Breelyn A.
    Reilley, Matthew J.
    Benson, Al B.
    Chow, Warren A.
    Konda, Bhavana
    Starr, Jason
    Ahn, Daniel H.
    Kunz, Pamela L.
    Strosberg, Jonathan R.
    Eads, Jennifer R.
    Perez, Kimberly J.
    Raj, Nitya P.
    Fisher, George A.
    Chollate, Sowmya
    Fleener, Catherine A.
    Ding, Ying
    Tang, Zequn
    PANCREAS, 2022, 51 (03) : E58 - E58
  • [36] NAV-003, a bispecific antibody targeting a unique mesothelin epitope and CD3ε with improved cytotoxicity against humoral immunosuppressed tumors
    Grasso, Luigi
    Jiang, Qun
    Hassan, Raffit
    Nicolaides, Nicholas C. C.
    Kline, J. Bradford
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 (08)
  • [37] PRODUCTION OF HYBRID BISPECIFIC ANTIBODY RECOGNIZING HUMAN COLORECTAL-CARCINOMA AND CD3 ANTIGEN
    XIANG, J
    PAN, ZQ
    ATTAHPOKU, S
    BABIUK, L
    ZHANG, Y
    LIU, EW
    MOLECULAR BIOTHERAPY, 1992, 4 (01) : 15 - 23
  • [38] Bispecific antibodies targeting CD3 in oncology and hematology
    Vanacker, Helene
    Vinceneux, Armelle
    Nicolas-Virelizier, Emmanuelle
    Brahmi, Mehdi
    Cassier, Philippe A.
    BULLETIN DU CANCER, 2021, 108 (10) : S181 - S194
  • [39] The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm
    Suurs, Frans, V
    Lorenczewski, Grit
    Stienen, Sabine
    Friedrich, Matthias
    de Vries, Elisabeth G. E.
    de Groot, Derk Jan A.
    Lub-de Hooge, Marjolijn N.
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (11) : 1594 - 1601
  • [40] A ROR1 SPECIFIC CD3 BISPECIFIC T-CELL ENGAGER ENGINEERED FOR SOLID TUMORS WITH AN EXPANDED THERAPEUTIC WINDOW
    Rabinovich, Brian
    Zhou, Xueyuan
    Takimoto, Jeffrey
    Song, Paul
    Alici, Evren
    Khanna, Nikhita
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1110 - A1110
12345